Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | PEDIATRIX MEDICAL GROUP, INC. MD | Rubric Capital Management LP | 8,275,000 9.640% | 8,275,000 (New Position) | Filing History |
| 2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Rubric Capital Management LP | 48,706,640 6.980% | 42,062,110 (+633.03%) | Filing History |
| 2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | QUIDELORTHO CORPORATION QDEL | Rubric Capital Management LP | 4,200,000 6.250% | 4,200,000 (New Position) | Filing History |
| 2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | RENEW ENERGY GLOBAL PLC SHS CL RNW | Rubric Capital Management LP | 13,706,102 5.610% | 13,706,102 (New Position) | Filing History |
| 2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | TREVI THERAPEUTICS INC TRVI | Rubric Capital Management LP | 5,026,931 6.920% | -657,489 (-11.57%) | Filing History |
| 2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | ZYMEWORKS INC ZYME | Rubric Capital Management LP | 3,917,331 5.510% | 3,917,331 (New Position) | Filing History |
| 2024-06-17 4:32 pm Purchase | 2024-06-17 | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 108,486,735 14.200% | 8,771,750 (+8.80%) | Filing History |
| 2024-06-11 4:05 pm Purchase | 2024-06-10 | 13D | XPERI INC XPER | Rubric Capital Management LP | 4,143,744 9.200% | 100,000 (+2.47%) | Filing History |
| 2024-05-31 5:24 pm Unchanged | 2024-05-31 | 13D | XPERI INC XPER | Rubric Capital Management LP | 4,043,744 9.000% | 0 (Unchanged) | Filing History |
| 2024-05-31 11:08 am Unchanged | 2023-11-14 | 13D | HERON THERAPEUTICS INC HRTX | Rubric Capital Management LP | 26,713,503 17.700% | 0 (Unchanged) | Filing History |
| 2024-04-16 2:58 pm Purchase | 2024-04-15 | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 99,714,985 14.220% | 10,100 (+0.01%) | Filing History |
| 2024-02-21 2:00 pm Purchase | 2024-02-20 | 13D | XPERI INC XPER | Rubric Capital Management LP | 4,043,744 9.300% | 307,525 (+8.23%) | Filing History |
| 2024-02-14 10:28 am Purchase | 2024-02-13 | 13D | XPERI INC XPER | Rubric Capital Management LP | 3,736,219 8.600% | 435,000 (+13.18%) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Rubric Capital Management LP | 6,644,530 7.040% | 6,644,530 (New Position) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | GOODRX HLDGS INC GDRX | Rubric Capital Management LP | 5,872,806 6.360% | 5,872,806 (New Position) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | GOLAR LNG LTD GLNG | Rubric Capital Management LP | 6,506,757 6.210% | 154,001 (+2.42%) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Rubric Capital Management LP | 2,907,501 8.210% | 2,907,501 (New Position) | Filing History |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | OVID THERAPEUTICS INC OVID | Rubric Capital Management LP | 5,315,969 7.520% | -1,512,096 (-22.15%) | Filing History |
| 2024-02-12 06:06 am Sale | 2023-12-31 | 13G | PAR PACIFIC HOLDINGS INC PARR | Rubric Capital Management LP | 1,199,749 1.980% | -1,849,251 (-60.65%) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | SCPHARMACEUTICALS INC SCPH | Rubric Capital Management LP | 3,500,000 9.760% | 3,500,000 (New Position) | Filing History |